DuPont Genetics LLC

dupontgenetics.com

DuPont Genetics Rooted in the Northeast in early 2012. Pioneering the cannabis industry at the forefront ever since.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

SLINGSHOT BIOSCIENCES, INC. PARTNERS WITH CAMBRIDGE BIOSCIENCE TO DISTRIBUTE SYNTHETIC CELLS THROUGHOUT UNITED KINGDOM AND IRELAND

Slingshot | June 16, 2022

news image

SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Cambridge Bioscience, a UK-based specialist distributor of life science research tools. The agreement entitles Cambridge Bioscience to the right to distribute and resell Slingshot ...

Read More

Medical

INTEGRATED DNA TECHNOLOGIES OPENS NEW THERAPEUTIC MANUFACTURING FACILITY TO SUPPORT GROWING DEMAND IN GENOMIC MEDICINE

businesswire | October 19, 2023

news image

Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the company’s 35-year-history—its entrance into the therapeutics spa...

Read More

Medical

JNANA THERAPEUTICS ANNOUNCES POSITIVE CLINICAL PROOF OF CONCEPT ACHIEVED WITH JNT-517, A POTENTIAL FIRST-IN-CLASS ORAL TREATMENT FOR PKU

Jnana Therapeutics, Inc. | February 02, 2024

news image

Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with phenylketonuria (PKU). JNT-517, a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19, is being evaluated as a potential first-in-class oral treatment for PKU across all age...

Read More

Industrial Impact, Medical

SYNTHEGO INTRODUCES CRISPR DISCOVERY PARTNERS TO STREAMLINE CRISPR-DRIVEN DRUG DISCOVERY RESEARCH

Synthego | March 17, 2023

news image

Synthego Corp., a leading genome engineering solutions provider, announced today the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services. The ecosystem brings together high-value partners including Arctoris, BrainXell, Curia, PhenoVista, and Pluristyx to offer a coordinated solution for CRISPR-driven drug discovery. The CR...

Read More
news image

Medical

SLINGSHOT BIOSCIENCES, INC. PARTNERS WITH CAMBRIDGE BIOSCIENCE TO DISTRIBUTE SYNTHETIC CELLS THROUGHOUT UNITED KINGDOM AND IRELAND

Slingshot | June 16, 2022

SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Cambridge Bioscience, a UK-based specialist distributor of life science research tools. The agreement entitles Cambridge Bioscience to the right to distribute and resell Slingshot ...

Read More
news image

Medical

INTEGRATED DNA TECHNOLOGIES OPENS NEW THERAPEUTIC MANUFACTURING FACILITY TO SUPPORT GROWING DEMAND IN GENOMIC MEDICINE

businesswire | October 19, 2023

Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the company’s 35-year-history—its entrance into the therapeutics spa...

Read More
news image

Medical

JNANA THERAPEUTICS ANNOUNCES POSITIVE CLINICAL PROOF OF CONCEPT ACHIEVED WITH JNT-517, A POTENTIAL FIRST-IN-CLASS ORAL TREATMENT FOR PKU

Jnana Therapeutics, Inc. | February 02, 2024

Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with phenylketonuria (PKU). JNT-517, a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19, is being evaluated as a potential first-in-class oral treatment for PKU across all age...

Read More
news image

Industrial Impact, Medical

SYNTHEGO INTRODUCES CRISPR DISCOVERY PARTNERS TO STREAMLINE CRISPR-DRIVEN DRUG DISCOVERY RESEARCH

Synthego | March 17, 2023

Synthego Corp., a leading genome engineering solutions provider, announced today the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services. The ecosystem brings together high-value partners including Arctoris, BrainXell, Curia, PhenoVista, and Pluristyx to offer a coordinated solution for CRISPR-driven drug discovery. The CR...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us